Deciphering von Hippel-Lindau (VHL/Vhl)-associated pancreatic manifestations by inactivating Vhl in specific pancreatic cell populations.
about
Systemic VHL gene functions and the VHL diseasePancreas-specific Cre driver lines and considerations for their prudent useElimination of von Hippel-Lindau function perturbs pancreas endocrine homeostasis in miceInsights into the Pathogenesis of Pancreatic Cystic Neoplasms.Conditional deletion of p53 and Rb in the renin-expressing compartment of the pancreas leads to a highly penetrant metastatic pancreatic neuroendocrine carcinoma.Multiple endocrine neoplasia type 1 deletion in pancreatic alpha-cells leads to development of insulinomas in micePrimary cilia in pancreatic development and disease.Mouse models of inherited cancer syndromesThe multifaceted von Hippel-Lindau tumour suppressor protein.EAF2 loss enhances angiogenic effects of Von Hippel-Lindau heterozygosity on the murine liver and prostate.Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways.Hypoxia-inducible factor 1 activation from adipose protein 2-cre mediated knockout of von Hippel-Lindau gene leads to embryonic lethality.Complex cellular functions of the von Hippel-Lindau tumor suppressor gene: insights from model organisms.Von Hippel-Lindau disease (VHL): a need for a murine model with retinal hemangioblastomaVHLdb: A database of von Hippel-Lindau protein interactors and mutations.Genetic modification of hypoxia signaling in animal models and its effect on cancer.Pancreatic cyst development: insights from von Hippel-Lindau disease.Stabilization of HIF-2α impacts pancreas growth
P2860
Q24605882-99560006-3004-43DB-B182-40B738E979C9Q27011305-F0DF97B0-88D0-48B2-B200-6357D5048C0BQ27309018-91B5EA4E-4E77-4126-8962-E6967C92FC30Q30234478-9406D759-F3DB-4CBC-9455-ABF84673F45BQ33700895-6DBCCEE7-B0FC-482A-B7AB-50FBA9372A30Q34132545-3BBF4DBF-DAE5-474D-BB6B-6EE4771A7BABQ34421859-06BEC959-8E44-40C8-81FD-FBDD8D61D2C1Q34447472-77DBAA6F-6207-4FD9-B597-140532F9483DQ34660062-4E38A6C1-CB83-4090-9FAB-821EC1658661Q35161330-72A3EA22-FE39-4DE9-B997-90C8BDB31180Q35641254-BC06CECA-D674-47AE-BAF8-E166170EFAE2Q35718056-D6558804-A078-407F-9BA7-77920667ABC1Q35931293-99B0C4F8-B239-48A8-9714-91BED3D4F2A4Q36123826-07658EBE-C316-49C8-B66E-3ADF8E6824B7Q37166626-BF0CE570-C380-42AD-8012-34AB4DFE2BD4Q38263349-05205A47-EDE3-4E2F-B382-71958B3B227FQ42055257-4F565303-E4E6-47C6-BA1E-FFA5E0185C13Q58747287-59DD88D5-085A-46D2-9EA7-980DDE48692F
P2860
Deciphering von Hippel-Lindau (VHL/Vhl)-associated pancreatic manifestations by inactivating Vhl in specific pancreatic cell populations.
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Deciphering von Hippel-Lindau ...... c pancreatic cell populations.
@ast
Deciphering von Hippel-Lindau ...... c pancreatic cell populations.
@en
type
label
Deciphering von Hippel-Lindau ...... c pancreatic cell populations.
@ast
Deciphering von Hippel-Lindau ...... c pancreatic cell populations.
@en
prefLabel
Deciphering von Hippel-Lindau ...... c pancreatic cell populations.
@ast
Deciphering von Hippel-Lindau ...... c pancreatic cell populations.
@en
P2093
P2860
P1433
P1476
Deciphering von Hippel-Lindau ...... c pancreatic cell populations.
@en
P2093
Arianne Wilson
David M Harlan
Dominique Lorang
H-C Jennifer Shen
Irina A Lubensky
Klaus Pechhold
Kris Ylaya
Laura S Schmidt
P2860
P356
10.1371/JOURNAL.PONE.0004897
P407
P577
2009-04-02T00:00:00Z